• Technology for uptake and nontransgenic expression of foreign DNA using virally derived plasmids in seed treatments for delivery
  • Company’s strategy will be to license its technology for seed treatment companies to include in their products
  • Recent trials with partners revealed tech...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

GreenLight Biosciences' Ledprona receives validation as a new MoA by the Insecticide Resistance Action Committee

News Commentary | April 07, 2022

Colorado potato beetles account for crop damage exceeding half a billion dollars worldwide and have easily developed resistance over the years to pesticides used on solanaceous crops, including potatoes. The first foliar application of a dsRNA‑based bioinsecticide, Calantha, has a unique mode of ... Not part of subscription

Marrone Bio Innovations

Company Profile | April 29, 2022

Marrone Bio Innovations (MBI) develops, produces, and commercializes biobased pest management and plant health products; in March 2022, merged with Biocere Crop Solutions The company currently has 18 commercial products and over 500 pending and granted patents across different areas ... Not part of subscription


Company Profile | May 19, 2022

Evogene developed a computational platform that uses machine learning algorithms to identify candidate genes, small molecules, and biologicals for agricultural applications Evogene forms strategic R&D partnerships to bring its identified candidates to market; the company is currently ... Not part of subscription